[SLN] YoY Annual Result on 31-Dec-2014 [#FY]

Stock
[SLN] Silence Therapeutics plc
Announcement Date
30-Dec-2014
Financial Year
2014
Quarter
31-Dec-2014 [#FY]
Profit Trend
YoY- -23.17%
Quarter Report
SLN's Result
SLN's Financial Summary
View:
Show?
Annual Result
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Revenue 16 770 0 15 117 163 694 -46.62%
PBT -3,775 -10,362 -9,429 -11,980 -9,002 -26,284 -5,737 -6.73%
Tax -2,157 -1,922 -2,784 -892 -70 -30 -49 87.79%
NP -1,618 -8,440 -6,645 -11,088 -9,002 -26,284 -5,737 -19.00%
Tax Rate - - - - - - - -
Total Cost 1,634 9,210 6,645 11,103 9,119 26,447 6,431 -20.39%
Ratio Analysis
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
NP Margin -10,112.50 -1,096.10 0.00 -73,920.00 -7,694.02 -16,125.15 -826.66 51.73%
Per Share
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
EPS -0.07 -0.36 -0.31 -0.66 -0.61 -4.11 -1.84 -41.97%
EPS Diluted -0.07 -0.36 -0.31 -0.66 -0.61 -4.11 -1.84 -41.97%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.